A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

NCT02402062 PHASE2 COMPLETED Results posted

The purpose of this study is to determine the safety and the efficacy of the combination of the drugs TH-302 and sunitinib in metastatic neuroendocrine tumours.

Details

Lead sponsor	Grupo Espanol de Tumores Neuroendocrinos
Phase	PHASE2
Status	COMPLETED
Enrolment	17
Start date	Mon May 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jan 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Neuroendocrine Tumors
• Pancreatic Neoplasms

Interventions

• TH-302 + Sunitinib

Countries

Spain